Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study
When this happens, the proximity between drug initiation and diagnosis becomes crucial evidence when pursuing a product liability claim
It is given as a series of injections around the head and neck every 12 weeks to reduce the frequency of headaches
For users that experience these side effects, your provider may suggest spacing out dose escalations even further (for example, increasing your dose every 6-8 weeks instead of every 4 weeks)
Holly Lofton, an obesity-medicine specialist at NYU, guesses that it affects just 2 percent of her patients